Pharmabiz9h
Neumora Therapeutics’ phase 3 KOASTAL-1 study of navacaprant in MDD fails to meet primary endpoint
Watertown, Massachusetts Friday, January 3, 2025, 18:00 Hrs [IST] ...
Pharmabiz10h
Centre notifies amendments to Foreign Trade Policy 2023 to enhance stakeholder engagement
Centre notifies amendments to Foreign Trade Policy 2023 to enhance stakeholder engagement: Shardul Nautiyal, Mumbai Friday, January 3, 2025, 17:50 Hrs [IST] The Union ministry of ...
Pharmabiz10h
Sammprada Hospital notes steep fall in cases of cervical cancer, insists government implementation for vaccination for girls of 9-14 years
Sammprada Hospital notes steep fall in cases of cervical cancer, insists government implementation for vaccination for girls of 9-14 years: Our Bureau, Bengaluru Friday, January 3 ...
Pharmabiz10h
NIMHANS golden jubilee had presence of President of India Droupadi Murmu grace the commemoration celebrations
NIMHANS golden jubilee had presence of President of India Droupadi Murmu grace the commemoration celebrations: Our Bureau, Bengaluru Friday, January 3, 2025, 17:30 Hrs [IST] Natio ...
Pharmabiz10h
DigiNerve empowers medical students by introducing enhanced NEET SS preparation module in Paediatrics MD Course
DigiNerve empowers medical students by introducing enhanced NEET SS preparation module in Paediatrics MD Course: Our Bureau, Bengaluru Friday, January 3, 2025, 17:15 Hrs [IST] Dig ...
Pharmabiz10h
Merck Sharp & Dohme’s sotatercept gets UK MHRA marketing approval to treat adult patients with pulmonary arterial hypertension
Merck Sharp & Dohme’s sotatercept gets UK MHRA marketing approval to treat adult patients with pulmonary arterial hypertension: United Kingdom Friday, January 3, 2025, 17:00 Hrs ...
Pharmabiz11h
National Institutes of Health officials assess threat of H5N1
National Institutes of Health officials assess threat of H5N1: Bethesda, Maryland Friday, January 3, 2025, 16:00 Hrs [IST] Highly pathogenic H5N1 avian influenza A virus (HPAI H5N ...
Pharmabiz12h
Atavistik Bio enters research collaboration with Pfizer to accelerate discovery of novel precision allosteric therapeutics
Atavistik Bio enters research collaboration with Pfizer to accelerate discovery of novel precision allosteric therapeutics: Cambridge, Massachusetts Friday, January 3, 2025, 15:00 ...
Pharmabiz14h
ANI Pharmaceuticals introduces US FDA approved prucalopride tablets
ANI Pharmaceuticals introduces US FDA approved prucalopride tablets: Princeton, New Jersey Friday, January 3, 2025, 14:00 Hrs [IST] ANI Pharmaceuticals, Inc., a diversified biopha ...
Pharmabiz14h
Hutchmed to divest its 45% equity interest in SHPL to GP Health Service Capital & Shanghai Pharma for approx. US$ 608 million
Hutchmed to divest its 45% equity interest in SHPL to GP Health Service Capital & Shanghai Pharma for approx. US$ 608 million: Hong Kong, Shanghai Friday, January 3, 2025, 13:00 H ...
Pharmabiz15h
Innovent inks exclusive global license agreement with Roche to advance the development of IBI3009, a novel DLL3 targeted ADC candidate
Innovent inks exclusive global license agreement with Roche to advance the development of IBI3009, a novel DLL3 targeted ADC candidate: San Francisco, US Friday, January 3, 2025, ...
Pharmabiz16h
UK MHRA grants marketing authorization to Amgen’s tarlatamab to treat adult patients with small cell lung cancer
UK MHRA grants marketing authorization to Amgen’s tarlatamab to treat adult patients with small cell lung cancer: United Kingdom Friday, January 3, 2025, 11:00 Hrs [IST] The UK ...